I think there are good reasons to submit a comment if you are a medical doctor, have a connection to aGvH, an advocate for people suffering on the disease, etc.
The rest of us as shareholders and/or hoping for a good result for humanity's health probably can't really influence the result.
Ann: FDA Advisory Committee Sets Review Date for Remestemcel-L, page-297
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.45 |
Change
0.070(5.09%) |
Mkt cap ! $1.592B | |||
| Open | High | Low | Value | Volume |
| $1.40 | $1.46 | $1.38 | $3.819M | 2.709M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 15322 | $1.44 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.45 | 3849 | 4 |
View Market Depth
| Last trade - 13.23pm 17/10/2024 (20 minute delay) ? |
| MSB (ASX) Chart |